Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
2-phosphoxylose phosphatase 1 (PXYLP1) is a phosphatase enzyme localized to the Golgi apparatus, responsible for removing phosphate at the 2-position of xylose in the glycosaminoglycan-protein linkage region of proteoglycans. This activity enables efficient elongation of glycosaminoglycan chains—especially chondroitin sulfate and heparan sulfate—by facilitating the addition of repeating disaccharide units. Mutations or deficiencies in PXYLP1 are associated with connective tissue disorders such as Ehlers-Danlos syndrome and skeletal dysplasias due to disruption in proteoglycan structure and function.
Mechanism is enzymatic dephosphorylation in glycosaminoglycan metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 2-phosphoxylose phosphatase 1 (PXYLP1).